Thank you for your interest, we’ll get in touch with you shortly!

Du använder Internet Explorer, en webbläsare som slutade utvecklas 6 november 2013, för över 9 år sedan. Den 31 januari 2020 upphörde även alla säkerhetsuppdateringar vilket innebär att webbläsaren, förutom funktionella och utseendemässiga brister även kan utgöra en säkerhetsrisk. Du rekommenderas starkt att uppgradera till en modernare webbläsare, t ex Google Chrome, Mozilla Firefox eller Microsoft Edge. Tala med din systemadministratör.
Visa inte detta meddelande igen
Logotype Interreg - European Regional Development Fund

Archive for september, 2022

HealthTech Nordic Conference 2022

Publicerad: 21 september, 2022 av Elida Cimic |

Thank you to all participants and guest speakers who joined us at the HealthTech Nordic international conference at HUONE in Copenhagen 8-9 September 2022. The ambition was to find a game plan that leads to smarter healthcare systems and tells us what needs to be done to get there. Which we did, and will work with going forward! The healthcare challenge is global, we need to work together to increase the implementation of healthtech.

Together we can break the waves towards smarter healthcare, for all.

Please find the full version of the recorded conference and interviews below.

AGENDA

1:35 HealthTech Nordic, Introduction
Marianne Larsson Director of HealthTech Nordic

13:01 QALY: A way to use health claims in your value proposition?
Filipa Sampaio and Camilla Nystrand, Health Economists at NordIQ Analytics, and Aldo Vermiglio and Johan Rosendahl Innovation Managers, at Innovation Skåne

40:49 Precision Health
Sofia Gerward, Head of Medical Affairs at Novo Nordisk

1:07:47 Public-private partnerships for healthcare AI
Tina Juul (PhD), Business Development Director at IQVIA

1:34:11 The importance of lowering barriers for procurers to identify state-of-art solutions
Nima Jokilaakso, PhD, Senior Advisor at Business Finland

2:06:52 How to become market leaders using co-creation
Andreas Dam, CEO of Daman

2:30:50 The future of digital health reimbursement
Jesper Grønbæk, Founder & CEO of Health Tech Hub Copenhagen

2:52:23 Panel: Hurdles for wide implementation in public healthcare systems, and how to overcome them. Moderator: Mette Smith Thastum, Special Advisor healthtech, Valentin Bejan, Co-Founder & Chief Innovation Officer at Health Tech Hub Copenhagen, Peter Kjäll HealthTech Lead at TechSverige and Mikael Rinnetmäki CEO of Sensotrend

3:21:06 The future must be Together
Towa Jexmark, Head of Innovation & Strategic partnership, and Sören Meelby, Business Innovation Director, at Ramsay Santé

3:48:30 Innovation in the Cloud – AWS Vision and Strategy for Healthcare
Harri Tatti, Sales Executive, EMEA Healthcare at Amazon Web Services (AWS)

4:21:10 The journey behind the vision to limit the spread of infectious diseases worldwide
Andreas Nyberg, CSO and founding partner at Diagonal Bio

4:44:42 How to create a scale-up: RTFM
Heidi Blengsli Aabel, CEO of CheckWare Norge

5:18:25 HealthTech Nordic conference, summary and what’s to come
Marianne Larsson Director of HealthTech Nordic

Short sum up of the conference

Our hosts sum up the days: Marianne Larsson Director of HealthTech Nordic, Annica Grimberg Lignell, Head of business department at Sahlgrenska Science Park, Bent-Håkon Lauritzen, Project manager and advisor at Norway Health Tech and, Anett Falussy, Head of Communications & Events at Health Tech Hub Copenhagen.

Interviews with participants at the conference

Margareta Wallentén, Project Manager at HealthTech Nordic, meets participants to find out what they will bring home from the two day conference – and what has been the best part.

New way of measuring health effects and public benefits of healthtech can facilitate decision making

Publicerad: 8 september, 2022 av Lovisa Demirci |

A new study has analysed data from healthtech companies to test whether it is possible to measure the societal impact, based on the solution’s impact on quality of life. The used method is already well established within other areas, and the analysis indicates an application of the method has a big potential. The study – which shows new ways to measure effects of health-tech solutions – will be presented at the HealthTech Nordic International Conference the 8th of September in Copenhagen.

The analysis was commissioned by HealthTech Nordic and aims to translate results from clinical studies to quality-adjusted life years “QALY”, which can be used to evaluate and compare different medical interventions. The method can also be useful in cost-effectiveness analyses and has, for example, been use for a long time by the pharmaceutical industry and healthcare providers when deciding what medicines may cost for the benefit they provide.

The method has, for example, been used for a long time by the pharmaceutical industry and healthcare providers when deciding what medicines may cost for the benefit they provide.

The idea of the study is to try to find a widely accepted, standardized and scientifically accepted way of evaluating the societal effect – also when introducing digital technology in the healthcare. Could it facilitate decision-making and contributing to a way of measuring the aggregate effects in society of introducing digital health technology.

– We wanted to explore new ways of measuring what effects health tech solutions have on the public health. The effects of new technology within healthcare is often difficult to measure, but this is an example which shows that it is possible, Johan Rosendahl, Innovation Leader at Innovation Skåne and HealthTech Nordic said.

The willingness to pay for a QALY-year is up to 500 000 SEK (46 700 EUR) for a moderate disease and up to 2 000 000 SEK (186 800 EUR) for uncommon, severe diseases according to The Dental and Pharmaceutical Benefits Agency (TLV). 

– This approach could provide important information to decision maker who are responsible for the development within healthcare. The data clarifies the effects and can hopefully contribute to better ways to measure effects of new solutions, Johan Rosendahl said and adds:

– We are aware that this method is based on one, of several, ways to measure. The long-term goal for us is to find a common way to evaluate the public benefit from innovations, and we want to encourage discussions about different ways to attack this issue, Johan Rosendahl said.

The QALY-analyse is done by NordIQ, a health economics and outcomes research consultancy.